Multispecific Anti Neutrophil Cytoplasm Antibodies: A case report

##plugins.themes.academic_pro.article.main##

Marouane Haddad
Meherzia Bourguiba
Najla Ghrairi
Hayet Bouakkez
Ibtissem Nahdi
Awatef Dahmouni
Ikram Drira
Sadok Yalaoui

Abstract

Aim : To report the presence af ANCA with an unusual polyreactivity.
Case report : 50 year-old woman with pulmonary fibrosis whose immunological investigations showed the presence of ANCA with an unusual polyreactivity against several neutrophil proteins (PR3,MPO, BPI, lysozyme, elastase and cathepsine G) which could be related to a polyclonal hypergammaglobulinemia occurring in this
patient.
Conclusion : The international consensus on the testing of ANCA recommends seeking major specificities like MPO and PR3 which are good markers of ANCA-associated vasculitides. The use of multiantigenic ELISA can be helpful to detect various target antigens at the same time and may thus explain some atypical fluorescent patterns observed when searching for ANCA by Indirect immunofluorescence, these results, however, must be interpreted with caution.

Keywords:

Anti Neutrophil Cytoplasm Antibodies. Indirect Immuno Fluorescence Enzym Linked ImmunoSorbent Assay. Specificity

##plugins.themes.academic_pro.article.details##

References

  1. Bosch X, Guilbert A , Font J. Antineutrophil cytoplasmic antibodies. Lancet 2006 ; 368 :404-418.
  2. Savige J, Gillis D, Benson E et al. International consensus statement on testing and reporting of anti neutrophil cytoplasmic antibodies (ANCA). Amj of Clin Pathol 1999; 111:507-513.
  3. Savige J, Davies D, Falk RJ et al. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney I. 2000; 57:846-862.
  4. Sghiri R, Meddeb H J, Bouguila J, Jarray M, Bahri F, Nouira R et al. Anti neutrophil cytoplasmic antibodies and associated diseases. Pathologie Biologie. 2009; 57:398-402.
  5. Talor M V, Stone JH, Stebbing, J,Barin J, Rose N R, Burek C L. Antibodies to selected minor target antigens in patients with antineutrophil cytoplasmic antibodies (ANCA).Clin. Exp Immunol 2007; 150:42-48.
  6. Savige JA, Paspaliaris B, Silvestrini R, Davies D, Nikoloutsopoulos T, Sturgess A et al. A Review of immunofluorescent patterns associated with antineutrophil cytolasmic antibodies (ANCA) and their differentiation from other antibodies. J Clinic Pathol 1998; 51:568-575.
  7. Wong RCW, Field K. MPO-ANCA may produce a combination of pANCA and atypical cytoplasmic ANCA indirect immunofluorescent patterns on certain ethanol fixed neutrophil substrates. J Clinic Pathol 2001; 54: 335.
  8. Pollock W, Clarke K, Gallagher K, et al. Immunofluorescent patterns produced by antineutrophil cytoplasmic antibodies (ANCA) vary depending on neutrophil substrate and conjugate. J Clinic Pathol 2002; 55:680-683.
  9. Beauvillain C, Delneste Y, Renier G, et al. Antineutrophil cytoplasmic autoantibodies: how should the biologist manage them ? Clinical Revew of allergy and immunology 2008;35:47-58.
  10. Schultz H. From infection to autoimmunity: A new model for induction of ANCA against the bactericidal/permeability increasing protein (BPI). Autoimm Rev 2007; 6: 223-227.
  11. Wiesner O, Russell KA, Lee AS et al. ANCA reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004; 50:2954-2965.
  12. Foulon G, Delaval P, Valeyre D, Wallaert B, DebrayMP, Brauner M et al. ANCA-associated lung fibrosis: Analysis of 17 patients. Resp Medi 2008; 102: 1392-1398.
  13. Hervier B, Pagnoux C, Agard C, et al. Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature .Ann of Rheum Diseases 2009; 68:404-407.